Firefly Neuroscience, Inc.
AIFF
$1.73
$0.052.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,075.76% | 2,890.00% | 258.33% | 178.95% | 43.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,075.76% | 2,890.00% | 258.33% | 178.95% | 43.48% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 342.42% | 2,640.00% | 258.33% | 178.95% | 43.48% |
| SG&A Expenses | -35.09% | 65.61% | 120.64% | 39.88% | 1,131.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.92% | 48.38% | 91.12% | 64.88% | 541.94% |
| Operating Income | 42.50% | -25.81% | -89.28% | -63.50% | -559.66% |
| Income Before Tax | 38.47% | -44.70% | -1,052.41% | -251.58% | -559.85% |
| Income Tax Expenses | -- | -- | -- | 100.00% | -- |
| Earnings from Continuing Operations | 38.47% | -45.02% | -1,052.41% | -251.44% | -559.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.47% | -45.02% | -1,052.41% | -251.44% | -559.85% |
| EBIT | 42.50% | -25.81% | -89.28% | -63.50% | -559.66% |
| EBITDA | 43.39% | -26.01% | -- | -63.61% | -562.63% |
| EPS Basic | 67.72% | 40.53% | -706.25% | -48.73% | -242.78% |
| Normalized Basic EPS | 70.21% | 42.27% | -501.19% | -13.91% | -242.93% |
| EPS Diluted | 67.72% | 40.53% | -706.25% | -48.73% | -242.78% |
| Normalized Diluted EPS | 70.21% | 42.27% | -501.19% | -13.91% | -242.93% |
| Average Basic Shares Outstanding | 90.62% | 143.88% | 91.67% | 136.27% | 92.47% |
| Average Diluted Shares Outstanding | 90.62% | 143.88% | 91.67% | 136.27% | 92.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |